India Collagen Market Size and Share

India Collagen Market (2026 - 2031)
View Global Report

India Collagen Market Analysis by Mordor Intelligence

The India collagen market size is expected to grow from USD 70.31 million in 2025 to USD 76.02 million in 2026 and is forecast to reach USD 112.27 million by 2031 at 8.13% CAGR over 2026-2031. The market growth is driven by significant demographic changes, including an aging population and increased health consciousness among younger consumers, as well as rising disposable incomes across urban areas. Government regulations continue to enhance quality standards and promote domestic production through the implementation of manufacturing incentives and quality control measures. The expanding fitness culture, particularly in metropolitan cities, combined with the growing demand for functional foods and premium pet nutrition products, creates diverse opportunities for collagen-infused products across multiple segments. Recent regulatory developments include the Food Safety and Standards Authority of India (FSSAI) 2025 packaging amendment, which allows recycled PET usage to promote sustainable packaging solutions, and the potential transfer of nutraceutical oversight to the Central Drugs Standard Control Organization (CDSCO). This transfer indicates heightened compliance requirements and stricter quality control measures for manufacturers and importers in the collagen market.

Key Report Takeaways

  • By source, animal-based collagen led with 54.48% of India collagen market share in 2025; marine-derived collagen is projected to rise at a 9.05% CAGR from 2026–2031.
  • By product type, gelatin commanded 48.05% of the Indian collagen market size in 2025, yet hydrolyzed collagen is expected to expand at an 8.64% CAGR.
  • By form, powder formats accounted for a 61.45% slice of the India collagen market share in 2025, while liquid formats are on track for an 8.53% CAGR.
  • By application, dietary supplements captured 57.78% of the 2025 India collagen market size; cosmetics and personal care are forecast to grow the quickest at a 8.93% CAGR through 2031.

Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of 2026.

Segment Analysis

By Source: Marine Sources Drive Sustainability Shift

Animal-based collagen holds a dominant market share of 54.48% in 2025, supported by well-established supply chains and cost advantages. Marine-based collagen is experiencing rapid growth with a 9.05% CAGR through 2031, driven by sustainability considerations and broader religious dietary acceptance. Bovine collagen leads the animal segment due to abundant raw materials and existing processing infrastructure. However, its market reach is limited in regions with significant Hindu populations. Porcine collagen faces market limitations due to Islamic dietary restrictions, creating distribution challenges for manufacturers. Marine collagen, despite higher prices, offers religious acceptability and environmental benefits that attract environmentally conscious consumers. The utilization of fish processing waste provides a cost-effective source for marine collagen production.

Biotechnology advancements have enabled the development of plant-based collagen alternatives. These include laboratory-produced vegan collagen, created by introducing human collagen genes into microorganisms. While these alternatives provide cruelty-free options, their production costs exceed traditional collagen sources. The combination of increasing sustainability demands and religious dietary considerations supports the continued growth of marine collagen, despite its premium pricing.

India Collagen Market: Market Share by Source, 2025
India Collagen Market: Market Share by Source, 2025

By Product Type: Hydrolyzed Formulations Gain Bioavailability Edge

Hydrolyzed collagen shows the highest growth rate at 8.64% CAGR through 2031, while gelatin maintains market dominance with a 48.05% share in 2025. Gelatin's market leadership position results from its widespread use in food and pharmaceutical applications, cost-effectiveness, and functional versatility across multiple end-uses. Native/undenatured collagen serves specific therapeutic segments, particularly in joint health applications where type II collagen's structural properties are essential and command premium prices. 

Hydrolyzed collagen peptides are gaining increasing adoption in dietary supplements and cosmetics due to superior absorption rates, supported by clinical evidence. Manufacturers leverage advanced processing technologies to produce hydrolyzed collagen with specific molecular weights for different applications. For example, Rousselot's Nextida GC platform demonstrates the expanding applications of hydrolyzed collagen, achieving a 42% reduction in post-meal glucose levels and extending beyond traditional joint health markets.

By Form: Liquid Formats Capture Premiumization Trends

Liquid collagen formats accelerate at 8.53% CAGR through 2031, driven by consumer preference for convenient consumption and perceived absorption benefits, while powder formats maintain market dominance with a 61.45% share in 2025, supported by their cost-effectiveness and versatility in product formulations. The powder segment's leadership position stems from efficient manufacturing processes, longer shelf life, and established distribution networks, particularly in price-sensitive markets. While liquid formulations command higher prices due to convenience and marketed absorption benefits, scientific evidence supporting superior bioavailability compared to powder formats remains limited. 

Urban consumers increasingly choose liquid formats for their ready-to-consume nature and convenience-focused lifestyle preferences. India's climate conditions present significant stability challenges for liquid collagen products, though technological solutions like GELITA's RXL address product degradation and crosslinking issues that affect product integrity. The requirements for specialized manufacturing processes and temperature-controlled distribution infrastructure restrict liquid format availability in rural areas, creating distinct market segments based on geographical accessibility and distribution capabilities.

India Collagen Market: Market Share by Form, 2025
India Collagen Market: Market Share by Form, 2025

By Application: Cosmetics Segment Accelerates Beauty-From-Within Trend

The cosmetics and personal care segment is projected to grow at a CAGR of 8.93% through 2031, while dietary supplements maintain market dominance with a 57.78% share in 2025. This growth reflects increasing consumer interest in beauty-from-within products and the premiumization trend in personal care. The cosmetics segment's growth is supported by higher profit margins, opportunities for brand differentiation, and consumer acceptance of premium pricing for beauty products. Dietary supplements maintain their market leadership position through established distribution networks, therapeutic positioning, and broad price accessibility. 

The food and beverages segment presents growth opportunities as manufacturers integrate marine collagen into functional foods, exemplified by Dabur's introduction of marine collagen formulations in FMCG channels. FSSAI regulations require manufacturers to substantiate cosmetic health benefit claims, providing competitive advantages to companies with clinical validation. The integration of nutraceutical and cosmetic properties has resulted in hybrid products that expand market opportunities across both supplement and beauty categories. Additional applications in medical and veterinary segments, while smaller, provide specialized opportunities for manufacturers with appropriate regulatory compliance.

Geography Analysis

India's collagen market shows significant domestic growth potential, driven by demographic shifts, regulatory changes, and increasing health awareness in urban and semi-urban areas. The aging population, rising disposable incomes, and growing interest in preventive healthcare contribute to market expansion. The proposed transfer of nutraceutical oversight from FSSAI to CDSCO may enhance quality standards, improve product safety monitoring, and create consolidation opportunities for manufacturers who meet compliance requirements.

Metropolitan areas such as Mumbai, Delhi, and Bangalore lead market adoption due to higher disposable incomes, advanced healthcare infrastructure, and elevated health consciousness. The southern states, particularly Karnataka and Tamil Nadu, exhibit robust growth in manufacturing and consumption, supported by established pharmaceutical and biotechnology hubs, research institutions, and skilled workforce availability. Coastal regions have access to marine collagen raw materials from fish processing industries, but face processing infrastructure constraints that limit supply capacity. These limitations include inadequate cold storage facilities, processing technology gaps, and quality control challenges. 

The government's BioE3 policy aims to strengthen biomanufacturing capabilities through infrastructure development, technology adoption incentives, and skill development programs. Rural markets face challenges in distribution networks, price sensitivity, and awareness gaps, though digital commerce expansion creates new access channels for collagen products. The limited healthcare infrastructure, inconsistent power supply, and seasonal accessibility issues further impact market penetration. However, government initiatives for rural development, increasing mobile connectivity, and the growth of telemedicine services present opportunities for market expansion in these regions.

Regulatory Landscape

Collagen ingredients and finished products marketed as health supplements/nutraceuticals in India sit primarily under the Food Safety and Standards Authority of India (FSSAI), notably the Food Safety and Standards (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Food for Special Medical Purpose, Functional Food and Novel Food) Regulations, 2016 and subsequent amendments. Where a collagen type, blend, or derivative is not covered under an existing standard, it can fall under the Food Safety and Standards (Approval for Non-Specified Food and Food Ingredients) Regulations, 2017, which requires an application and assessment route prior to commercialization.

Regulatory activity around non-specified ingredients remains visible through FSSAI maintained public status lists, including updates published through June 2026, which signal ongoing scrutiny of collagen-based ingredients and blends. On the trade side, amendments to the Export Policy for Animal By-products explicitly covering collagen peptides (including marine, bovine, and poultry origin) under ITC HS Code 35040010 add compliance touchpoints for exporters in addition to domestic food-safety and labeling controls.

Competitive Landscape

The Indian collagen market demonstrates moderate consolidation, with a 6 out of 10 rating. This market structure allows both established multinational companies and emerging domestic firms to gain market share through distinct strategies. Established companies such as GELITA use technological innovations, including RXL gelatin, to address regional climate challenges, particularly in maintaining product stability during storage and transportation. 

Market opportunities exist in specialized segments like glucose management, collagen for diabetic patients, marine-based formulations derived from fish scales and skin, and pet nutrition supplements targeting the growing companion animal market, where regulatory requirements create competitive advantages. Companies that invest in bioavailability enhancement through peptide optimization, stability solutions for tropical climates using advanced encapsulation techniques, and sustainable sourcing methods such as traceable supply chains, gain advantages in premium market segments. 

The Food Safety and Standards Authority of India (FSSAI) regulatory framework benefits established companies with robust quality systems, including Good Manufacturing Practice (GMP) certifications and quality testing protocols. Potential Central Drugs Standard Control Organisation (CDSCO) oversight may further consolidate the market by increasing entry barriers through stricter quality control requirements and documentation processes. New market entrants are developing plant-based alternatives using pea protein and biotechnology-derived collagen through recombinant protein expression, though high production costs and limited consumer acceptance currently restrict widespread adoption.

India Collagen Industry Leaders

  1. Jellice Group

  2. Nitta Gelatin Inc.

  3. Gelita AG

  4. Titan Biotech

  5. Rousselot (Darling Ingredients)

  6. *Disclaimer: Major Players sorted in no particular order
India Collagen CL.png

Market Opportunities and Future Outlook

Capacity addition and domestic capability building remain a key whitespace, particularly for higher-value collagen peptides used across nutraceutical and beauty-from-within formats. Nitta Gelatin India initiated an expansion project at its Kakkanad (Kochi) facility in April 2024 (INR 460 million) to lift collagen peptide capacity from 600 MT to 1,150 MT per year, and the company also outlined a broader INR 200 crore expansion drive in its golden jubilee year. These investments raise competitive intensity around consistent peptide supply, application support, and the ability to serve both domestic brands and export requirements with India-made material.

Opportunities also sit in marine-sourced collagen built on up-cycling fish-processing and aquaculture streams, which can reduce dependence on constrained animal-origin inputs and improve religious acceptability for certain consumer segments. In India, companies such as Nizona Marine Products (IKIGEN) and its Biowearth Global division illustrate a combined model of marine collagen peptide production and contract manufacturing for gummies, functional beverages, and premixes, aligning ingredient supply with finished-format execution. As FSSAI approval pathways for non-specified ingredients remain active, product developers have a clearer incentive to standardize dossiers, claims substantiation, and label compliance for collagen in functional foods, supplements, and hybrid beauty-nutrition propositions.

Recent Industry Developments

  • June 2026: FSSAI continued publishing updated public status lists for applications under the non-specified food and food ingredient approval process, providing ongoing visibility into regulatory review of ingredient submissions relevant to collagen derivatives and blends. This reinforces the need for compliant dossiers and can influence time-to-market for novel collagen formats and proprietary formulations across supplements and functional foods.
  • July 2025: Nitta Gelatin India highlighted its INR 200 crore expansion program alongside a planned collagen peptide capacity build-out at its Kakkanad, Kochi operations. The move strengthens domestic supply depth for collagen peptides and supports broader downstream product innovation in dietary supplements, beauty-from-within offerings, and functional foods.
  • April 2024: Nitta Gelatin India commenced an INR 460 million expansion project at its Kakkanad facility to raise collagen peptide capacity from 600 MT to 1,150 MT annually. The project signals investment into higher-margin peptide capabilities and adds scale for brands seeking India-based sourcing for standardized collagen ingredients.

Table of Contents for India Collagen Industry Report

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET LANDSCAPE

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Aging population and beauty consciousness
    • 4.2.2 Sports and performance nutrition
    • 4.2.3 Expansion of functional food and beverage offerings
    • 4.2.4 Pet health and animal nutrition
    • 4.2.5 Increasing vegan and specialty source options
    • 4.2.6 Product label transparency and clean-label demand
  • 4.3 Market Restraints
    • 4.3.1 Raw-material supply limitations
    • 4.3.2 Religious and ethical dietary restrictions
    • 4.3.3 Stability and shelf-life issues
    • 4.3.4 Evidence gap and consumer skepticism on efficacy
  • 4.4 Supply-Chain Analysis
  • 4.5 Regulatory and Technological Outlook
  • 4.6 Porter’s Five Forces Analysis
    • 4.6.1 Threat of New Entrants
    • 4.6.2 Bargaining Power of Buyers
    • 4.6.3 Bargaining Power of Suppliers
    • 4.6.4 Threat of Substitutes
    • 4.6.5 Intensity of Competitive Rivalry

5. MARKET SIZE AND GROWTH FORECASTS (VALUE AND VOLUME)

  • 5.1 By Source
    • 5.1.1 Animal-Based
    • 5.1.2 Marine-Based
    • 5.1.3 Plant-Based
  • 5.2 By Product Type
    • 5.2.1 Gelatin
    • 5.2.2 Hydrolyzed Collagen
    • 5.2.3 Native/Undenatured Collagen
  • 5.3 By Form
    • 5.3.1 Powder
    • 5.3.2 Liquid
  • 5.4 By Application
    • 5.4.1 Food and Beverages
    • 5.4.2 Cosmetics and Personal Care
    • 5.4.3 Dietary Supplements
    • 5.4.4 Others

6. COMPETITIVE LANDSCAPE

  • 6.1 Market Concentration
  • 6.2 Strategic Moves
  • 6.3 Market Ranking Analysis
  • 6.4 Company Profiles {(includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)}
    • 6.4.1 Nitta Gelatin India Ltd
    • 6.4.2 Gelita AG
    • 6.4.3 Rousselot (Darling Ingredients)
    • 6.4.4 Jellice Group
    • 6.4.5 Wellbeing Nutrition
    • 6.4.6 HealthKart (HK Vitals)
    • 6.4.7 Carbamide Forte
    • 6.4.8 Titan Biotech
    • 6.4.9 Shiseido
    • 6.4.10 Dabur India
    • 6.4.11 Abbott India
    • 6.4.12 Herbalife Nutrition
    • 6.4.13 Cargill
    • 6.4.14 Darling Ingredients India
    • 6.4.15 Lumenis
    • 6.4.16 Cutera
    • 6.4.17 EndyMed Medical
    • 6.4.18 Integra LifeSciences
    • 6.4.19 Coloplast
    • 6.4.20 Smith & Nephew
    • 6.4.21 Johnson & Johnson

7. MARKET OPPORTUNITIES AND FUTURE OUTLOOK

Research Methodology Framework and Report Scope

Market Definition and Coverage

This market covers collagen ingredients and collagen-based products sold and consumed in India, measured as the revenues generated from collagen used across food, supplements, personal care, and selected animal nutrition uses.

Scope exclusions: We exclude collagen naturally present in fresh foods, non-collagen proteins, and medical device and implant revenues where collagen is only a minor coating or processing aid.

Segmentation Overview
  • By Source
    • Animal-Based
    • Marine-Based
    • Plant-Based
  • By Product Type
    • Gelatin
    • Hydrolyzed Collagen
    • Native/Undenatured Collagen
  • By Form
    • Powder
    • Liquid
  • By Application
    • Food and Beverages
    • Cosmetics and Personal Care
    • Dietary Supplements
    • Others

Data Sources, Market Sizing, and Validation

Desk Research

Desk research was used to set the India level demand context and the operating boundaries for collagen, before the model was built. We reviewed public policy and compliance information that influences what can be sold and how it is labeled, along with trade and manufacturing signals that show supply direction.

Sources were taken from non paywalled, official, or widely cited references such as FSSAI notifications and guidance, Government of India trade and tariff information (DGFT), World Bank WITS and UN Comtrade trade tables, and peer reviewed papers on collagen use and safety. We also used annual reports, investor presentations, and reputable press coverage to understand application focus and product positioning, while a paid subscription for company financials and a shipment level trade database were used only for cross checks. The sources listed here are illustrative, and many other public sources were also referred to for data collection, validation, and clarification.

Primary Interviews and Surveys

Primary work was done to turn scattered public signals into usable assumptions, especially where collagen is sold through multiple channels and with different purity and format levels. We spoke with manufacturers, importers and formulators, contract packers, brand side commercial teams, and downstream buyers across supplements, food processing, and personal care. We then reconciled the inputs by geography and end use so the final totals stayed consistent with how products are actually bought and specified in India.

Because India has strong regional consumption differences, we validated the mix across metro led online demand as well as offline pharmacy and modern trade led demand. We also checked pricing, then reviewed the volume conversion factors used to translate labeled pack formats into collagen consumption.

Distribution of primary research fieldwork respondents

Company type Respondent position Region
Top tier: 35% CXOs: 13%
Mid tier: 45% Functional/Unit leaders: 35%
Smaller Players: 20% Managers: 52%

Market-Sizing & Forecasting

Our sizing logic starts with a top-down build where India demand is reconstructed from end use pools for supplements, food and beverages, and personal care, and then converted into collagen consumption using penetration rates and typical inclusion levels. To keep the total grounded, we also ran bottom-up approximations using sampled supplier revenues, channel checks in nutraceutical retail, and an ASP times volume build for a short list of high moving formats. The model was adjusted where the two views did not align.

Key inputs used in the model include the share of collagen peptides versus gelatin in labeled products, average realized pricing by form (powder versus liquid), import dependency and local processing share, application mix shifts between supplements and food use, and expected labeling and compliance impacts on product launches. Forecasts were built using scenario analysis with a base case guided by expert views on volume growth and price normalization, followed by sensitivity checks on import prices, consumer adoption, and regulatory tightening. Where direct volume evidence was thin, gaps were handled by using conservative ranges from interviews and then narrowing them through trade signals and repeat checks across multiple respondent groups.

Data Validation & Update Cycle

Validation was done through multiple passes so the final values stayed consistent with independent signals. We compared the model outputs against trade flows, price bands, and observed product launch intensity, and any outliers were flagged and rechecked with follow up calls.

Before sign off, another analyst reviewed assumptions, unit conversions, and CAGR math, and then the draft was refined until major variances were explained. Reports refresh annually, and interim updates are made when material events occur such as major regulation changes, sudden import price moves, or demand shocks. Before delivery, a final pass is completed so clients receive the latest updated view.

Mordor Intelligence's India Collagen Market Sizing Compared With Other Published Estimates

Published market numbers for collagen in India can look far apart because each publisher chooses a different product and application scope, and then prices the market with its own channel mix assumptions. The year used as the anchor point also matters, since collagen pricing can move with raw material costs and import conditions.

The main gap comes from whether collagen is counted only in supplements or also across food, beverages, personal care, and animal nutrition, which changes the demand pool a lot. In that setup, Mordor Intelligence treats the market as a wider set of collagen uses with value and volume measured across those applications instead of only finished supplement sales.

Benchmark comparison

Source Market Size Gaps in Research Methodology
Mordor Intelligence USD 70.31 M (2025)
Industry Portal A USD 169.94 M (2024) This figure is positioned as collagen supplements in India, so it can run higher than a collagen ingredients plus multi end use model when finished product retail pricing and broader supplement inclusions are applied. It also uses 2024 as the anchor year, which can reflect a different price level versus 2025.
Trade Blog B USD 82.45 M (2026) This estimate is framed around the collagen supplement market and is discussed mainly through urban demand, which can miss non supplement collagen consumption in food processing and personal care. The higher 2026 value can also come from carrying forward faster near term growth assumptions without clear volume conversion checks.

Taken together, the spread is mostly explained by what is being counted and at which point in the value chain it is priced. By keeping assumptions tied to application level demand pools, realistic penetration rates, and price bands that can be checked again, the resulting total stays traceable and repeatable for planning decisions.

Key Questions Answered in the Report

What is the projected value of the India collagen market in 2031?

The market is expected to reach USD 112.27 million by 2031, growing at an 8.13% CAGR over 2026-2031.

Which collagen source is expanding fastest in India?

Marine collagen is the fastest-growing source, forecast to post a 9.05% CAGR due to sustainability and religious neutrality advantages.

Why are hydrolyzed collagen products gaining popularity?

Hydrolyzed formats offer smaller peptides that absorb more efficiently, supporting joint, skin, and metabolic health claims and driving an 8.64% CAGR.

How is regulation shaping the India collagen space?

FSSAI labeling reforms and the possible shift of nutraceutical oversight to CDSCO are tightening quality controls, favoring manufacturers with GMP-grade facilities.

Page last updated on:

Native Collagen Market Size

India Collagen Market Report Snapshots